PCOS患者内脏脂肪含量与其糖代谢、胰岛素抵抗的相关研究
Study on Relationship between Visceral Adipose Tissue and Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovarian Syndrome
DOI: 10.12677/acm.2024.14123190, PDF,    科研立项经费支持
作者: 潘霞明*, 钟春媚, 肖隐霞, 黄妙玲, 武红梅:深圳市龙岗中心医院内分泌科,广东 深圳;徐定英:深圳市龙岗中心医院门诊部,广东 深圳;朱世飞:深圳市龙岗中心医院产科,广东 深圳;张冬梅:深圳市龙岗中心医院妇科,广东 深圳
关键词: 多囊卵巢综合征胰岛素抵抗糖代谢紊乱内脏脂肪面积Polycystic Ovary Syndrome Insulin Resistance Glucose Metabolism Disorders Visceral Adipose Tissue
摘要: 目的:探讨正常糖耐量组(NGT组)与糖尿病前期组(IGT组)多囊卵巢综合征(PCOS)患者内脏脂肪含量与其糖代谢、胰岛素抵抗(IR)的相关性。方法:回顾性收集2021年1月至2024年6月诊治的65例PCOS患者的临床资料,根据血糖情况分为NGT组和IGT组,其中NGT组31例,IGT组34例。比较2组临床资料、肥胖指标水平,分析比较BMI、SAT、VAT对IR的影响程度及预测价值。结果:两组的年龄、PCOS表型、月经周期、FINS、TG、LDL-C、FSH、T、SAT差异均无统计学意义(P > 0.05)。IGT组的FPG、HOMA-1R、TC、BMI、VAT均高于NGT组(P < 0.05),NGT组的LH水平大于IGT组(P < 0.05)。曲线拟合图显示VAT与FPG、HOMA-1R在一定程度上呈正相关(P < 0.05)。Logistic回归分析结果显示VAT为PCOS患者IR风险的危险因素[OR (95% CI) = 1.054 (1.006~1.105), P < 0.05],VAT预测IR的曲线下面积(AUC)为0.717 (95% CI 0.514~0.920),最佳临界值为81 cm2。结论:VAT高的PCOS更容易出现糖代谢紊乱、IR,VAT对IR具有一定的预测价值。
Abstract: Objective: To investigate the correlation between visceral fat content, glucose metabolism and insulin resistance (IR) in patients with polycystic ovary syndrome (PCOS) in normal glucose tolerance group (NGT group) and impaired glucose tolerance group (IGT group). Methods: Collected the clinical data of 65 PCOS patients diagnosed and treated in Longgang District Central Hospital of Shenzhen from 2021 to 2024, and divided them into hyperglycemia PCOS group (NGT-group) 31 cases and orthoglycemic PCOS group (IGT-group) 34 cases. Compare the two groups of clinical data, obesity index level, analyze and compare the influence degree and predictive value of BMI, VAT and SAT on IR. Results: The difference of age, PCOS phenotype, menstrual cycle, FINS, TG, LDL-C, FSH, T, SAT between the two PCOS group were not statistically significant (P > 0.05). The FPG, HOMA-1R, TC, BMI, VAT of the IGT-group were significantly higher than those of NGT-group (P < 0.05), the LH of the NGT-group was significantly higher than that of IGT-group (P < 0.05). Curve fitting analysis showed that VAT was positively correlated with IR and abnormal glucose metabolism. Logistic regression analysis showed that elevated VAT was risk factor for IR in PCOS patients [OR (95% CI) = 1.054 (1.006~1.105), P < 0.05], The area under the curve (AUC) of VAT predicted IR is 0.717 (95% CI 0.514~0.920), and the best critical value is 81 cm2. Conclusion: PCOS patients with high visceral fat content are more likely to have glucose metabolism disorders and insulin resistance, VAT has a certain predictive value for IR.
文章引用:潘霞明, 徐定英, 朱世飞, 张冬梅, 钟春媚, 肖隐霞, 黄妙玲, 武红梅. PCOS患者内脏脂肪含量与其糖代谢、胰岛素抵抗的相关研究[J]. 临床医学进展, 2024, 14(12): 1088-1096. https://doi.org/10.12677/acm.2024.14123190

参考文献

[1] Kakoly, N., Moran, L., Teede, H. and Joham, A. (2018) Cardiometabolic Risks in PCOS: A Review of the Current State of Knowledge. Expert Review of Endocrinology & Metabolism, 14, 23-33. [Google Scholar] [CrossRef] [PubMed]
[2] Zeng, X., Xie, Y., Liu, Y., Long, S. and Mo, Z. (2020) Polycystic Ovarian Syndrome: Correlation between Hyperandrogenism, Insulin Resistance and Obesity. Clinica Chimica Acta, 502, 214-221. [Google Scholar] [CrossRef] [PubMed]
[3] 多囊卵巢综合征诊治路径专家共识编写组, 李蓉, 段洁, 等. 多囊卵巢综合征诊治路径专家共识[J]. 中华生殖与避孕杂志, 2023(4): 337-345.
[4] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[5] 袁莹莹, 赵君利. 多囊卵巢综合征流行病学特点[J]. 中国实用妇科与产科杂志, 2019(35): 261-264.
[6] 尹静. 肥胖型与非肥胖型多囊卵巢综合征患者超声参数、内分泌指标及胰岛功能的差异性分析[J]. 临床医学, 2020, 40(2): 81-83.
[7] Livadas, S., Androulakis, I., Angelopoulos, N., Lytras, A., Papagiannopoulos, F. and Kassi, G. (2020) Liraglutide Administration Improves Hormonal/Metabolic Profile and Reproductive Features in Women with HAIR-AN Syndrome. Endocrinology, Diabetes & Metabolism Case Reports, 2020, 214-221. [Google Scholar] [CrossRef] [PubMed]
[8] Barber, T.M. and Franks, S. (2021) Obesity and Polycystic Ovary Syndrome. Clinical Endocrinology, 95, 531-541. [Google Scholar] [CrossRef] [PubMed]
[9] 帅祥煜, 任燕丽. 人体不同部位脂肪与肥胖相关疾病的关系研究概述[J]. 体育医学, 2021(5): 101-102.
[10] 王婵. 脂肪组织在多囊卵巢综合征中的研究进展[J]. 中国妇幼保健, 2018, 33(22): 5297-5300.
[11] 苏汇茹. 超声测量各部位脂肪厚度与肥胖相关疾病的相关性研究[D]: [硕士学位论文]. 成都: 成都医学院, 2020.
[12] Matsuzaki, T., Tungalagsuvd, A., Iwasa, T., Munkhzaya, M., Yano, K., Mayila, Y., et al. (2017) Clinical Outcome of Various Metformin Treatments for Women with Polycystic Ovary Syndrome. Reproductive Medicine and Biology, 16, 179-187. [Google Scholar] [CrossRef] [PubMed]
[13] Rocha, A.L., Oliveira, F.R., Azevedo, R.C., Silva, V.A., Peres, T.M., Candido, A.L., et al. (2019) Recent Advances in the Understanding and Management of Polycystic Ovary Syndrome. F1000 Research, 8, Article 565. [Google Scholar] [CrossRef] [PubMed]
[14] 沈涌海, 施新颜, 邱媛, 等. 多囊卵巢综合征患者血清FAI与AMH、IR的相关性研究[J]. 预防医学, 2018, 30(5): 467-470.
[15] 孙淼, 张晓颖, 李洋洋, 等. 多囊卵巢综合征低度慢性炎症与肥胖的关系[J]. 河北医科大学学报, 2021, 42(7): 823-826.
[16] Taylor, E.B. (2021) The Complex Role of Adipokines in Obesity, Inflammation, and Autoimmunity. Clinical Science, 135, 731-752. [Google Scholar] [CrossRef] [PubMed]
[17] Kim, J., Kim, J., Jo, M., Cho, E., Ahn, S., Kwon, Y., et al. (2022) The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome. Molecules, 27, Article 334. [Google Scholar] [CrossRef] [PubMed]
[18] 褚冉, 梁毓. 多囊卵巢综合征患者血清脂肪因子Asprosin、Apelin-13表达及与胰岛素抵抗关系[J]. 中国计划生育学杂志, 2022, 30(4): 846-850.
[19] de Medeiros, S.F., de Medeiros, M.A.S., Barbosa, B.B. and Yamamoto, M.M.W. (2021) The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome. Metabolic Syndrome and Related Disorders, 19, 18-25. [Google Scholar] [CrossRef] [PubMed]
[20] 刘丽, 张燕, 李萍, 等. 超重肥胖PCOS患者胰岛素抵抗与人体成分指标相关性研究[J]. 宁夏医学杂志, 2021, 43(12): 1096-1099.
[21] 董梦姣, 张杉杉, 李程, 等. 多囊卵巢综合征患者肥胖指标对胰岛素抵抗的预测价值[J]. 疑难病杂志, 2021, 20(8): 811-815.
[22] Liu, Y., Ding, Q., et al. (2017) Correlation between Osteo-Calcin and Visceral Fatareain over Weight and Obese Male Population. International Journal of Clinical and Experimental Medicine, 10, 6980-6986.